Clinical Trial Update: Management of Participants With Low-level Persistent Viremia (ANRS 161 L-VIR) [Phase 3]

View source ↗

Summary

Phase 3 trial ANRS 161 L-VIR evaluating management of participants with low-level persistent HIV-1 viremia; the study status is TERMINATED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: ANRS, Emerging Infectious Diseases | Conditions: HIV-1 Infection, Treatment Resistant Disorders | Phase 3 | Status: TERMINATED